JP2024507414A5 - - Google Patents
Info
- Publication number
- JP2024507414A5 JP2024507414A5 JP2023575684A JP2023575684A JP2024507414A5 JP 2024507414 A5 JP2024507414 A5 JP 2024507414A5 JP 2023575684 A JP2023575684 A JP 2023575684A JP 2023575684 A JP2023575684 A JP 2023575684A JP 2024507414 A5 JP2024507414 A5 JP 2024507414A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- membered
- group
- pharmaceutical composition
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152260P | 2021-02-22 | 2021-02-22 | |
| US63/152,260 | 2021-02-22 | ||
| PCT/US2022/017312 WO2022178420A1 (en) | 2021-02-22 | 2022-02-22 | Rock2 inhibitor for the treatment of viral infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507414A JP2024507414A (ja) | 2024-02-19 |
| JP2024507414A5 true JP2024507414A5 (cg-RX-API-DMAC7.html) | 2025-02-26 |
Family
ID=82931820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575684A Pending JP2024507414A (ja) | 2021-02-22 | 2022-02-22 | ウイルス感染症治療のためのrock2阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240165116A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4301132A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024507414A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240009918A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117529320A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022224669A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3209240A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022178420A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202327608A (zh) * | 2021-09-17 | 2023-07-16 | 北京泰德製藥股份有限公司 | 治療病毒感染的方法 |
| CA3231781A1 (en) * | 2021-09-18 | 2023-03-23 | Beijing Tide Pharmaceutical Co., Ltd. | Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof |
| US12637461B2 (en) | 2022-10-18 | 2026-05-26 | Pfizer Inc. | Compounds for the activation of AMPK |
| WO2024220173A1 (en) * | 2023-04-18 | 2024-10-24 | Genosco Inc. | Blood brain barrier penetrating selective inhibitors of rock2 protein kinases and uses thereof |
| EP4698528A1 (en) * | 2023-04-18 | 2026-02-25 | Genosco Inc. | Selective inhibitors of rock2 protein kinases and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470137A (en) * | 1967-02-14 | 1969-09-30 | Du Pont | Inter se copolymers of bicyclo(1.1.0)butanes |
| WO2015025172A1 (en) * | 2013-08-22 | 2015-02-26 | Mark David Charles | 5-aryl-thiazol-2-yl-amine compounds and their therapeutic use |
| CA3155220C (en) * | 2016-03-02 | 2024-01-16 | Gilead Apollo, Llc | Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof |
| EP3308786A1 (en) * | 2016-10-13 | 2018-04-18 | ETH Zurich | Fgfr regulaton for the treatment of viral infections |
| JP6593305B2 (ja) * | 2016-11-09 | 2019-10-23 | 株式会社村田製作所 | 二次電池用電解液、二次電池、電池パック、電動車両、電力貯蔵システム、電動工具および電子機器 |
| JP7311228B2 (ja) * | 2017-06-30 | 2023-07-19 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 |
| TWI804743B (zh) * | 2019-06-25 | 2023-06-11 | 大陸商北京泰德製藥股份有限公司 | 治療特發性肺纖維化的方法 |
| CN118772118A (zh) * | 2020-08-31 | 2024-10-15 | 北京泰德制药股份有限公司 | Rho相关蛋白激酶抑制剂的盐、其固体形式及其制备方法和用途 |
| CA3231781A1 (en) * | 2021-09-18 | 2023-03-23 | Beijing Tide Pharmaceutical Co., Ltd. | Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof |
| EP4434513A4 (en) * | 2021-11-16 | 2025-11-19 | Beijing Tide Pharmaceutical Co Ltd | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND ITS PREPARATION PROCESS |
| EP4561579A1 (en) * | 2022-07-27 | 2025-06-04 | Graviton Bioscience BV | Rock2 inhibitors for the treatment of viral infections |
-
2022
- 2022-02-22 CA CA3209240A patent/CA3209240A1/en active Pending
- 2022-02-22 AU AU2022224669A patent/AU2022224669A1/en active Pending
- 2022-02-22 KR KR1020237031854A patent/KR20240009918A/ko active Pending
- 2022-02-22 CN CN202280030027.8A patent/CN117529320A/zh active Pending
- 2022-02-22 JP JP2023575684A patent/JP2024507414A/ja active Pending
- 2022-02-22 EP EP22757114.8A patent/EP4301132A4/en active Pending
- 2022-02-22 US US18/547,257 patent/US20240165116A1/en active Pending
- 2022-02-22 WO PCT/US2022/017312 patent/WO2022178420A1/en not_active Ceased